FDA NDC Directory · JSON-LD · Markdown

Cefazolin

NDC 60505-6231 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, FOR SOLUTION

Labeler / ManufacturerApotex Corp.
Marketing categoryAbbreviated NDA (generic) · App ANDA203661
Dosage form / routeINJECTION, POWDER, FOR SOLUTION · INTRAMUSCULAR INTRAVENOUS
Active ingredientsCEFAZOLIN SODIUM (2 g/1)
Marketing started20220318
Package count1

External sources

Source: openFDA. Public-domain (CC0).